Background: Most abdominal aortic aneurysms (AAA) have large volumes of intraluminal
thrombus which has been implicated in promoting the risk of major adverse events. The aim …

Objective We investigated the association between new-onset atrial fibrillation (AF) and risk
of stroke and myocardial infarction (MI) in patients with abdominal aortic aneurysmal (AAA) …

Objectives The role of antithrombotic therapy in the management of aortic and peripheral
aneurysms is unclear. This systematic review and meta-analysis aimed to assess the impact …

Objective The relationship between intraluminal thrombus (ILT) and abdominal aortic
aneurysm (AAA) growth and rupture risk remains ambiguous. Studies have shown a limited …

Major adverse cardiovascular events (MACE), including myocardial infarction (MI), stroke
and cardiovascular death, cause substantial morbidity and mortality. This review assessed …

Objective There is no medical treatment proven to limit abdominal aortic aneurysm (AAA)
progression. This systematic review aimed to summarise available trial evidence on the …

OBJECTIVE: Datasets regarding patients with abdominal aortic aneurysm (AAA) have
almost universally been restricted to single geographic regions. We aimed to obtain data on …

An abdominal aortic aneurysm (AAA) is a focal full thickness dilatation of the abdominal
aorta, greater than 1.5 times its normal diameter. Although some patients with AAA …

Abdominal aortic aneurysm (AAA) volume and intraluminal thrombi were analyzed with
respect to the number and function of platelets, blood cells, and coagulation factors. A group …

Abdominal aortic aneurysm (AAA) is a degenerative vascular pathology resulting in
significant morbidity and mortality in older adults due to rupture and sudden death. Despite …